A Single Dose Bioequivalence Study Comparing the Commercial Tablet Formulation to the Clinical Tablet of Bosutinib in Healthy Subjects.

Trial Profile

A Single Dose Bioequivalence Study Comparing the Commercial Tablet Formulation to the Clinical Tablet of Bosutinib in Healthy Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 03 Sep 2010

At a glance

  • Drugs Bosutinib (Primary)
  • Indications Acute lymphoblastic leukaemia; Breast cancer; Myeloid leukaemia; Solid tumours
  • Focus Pharmacokinetics
  • Sponsors Wyeth
  • Most Recent Events

    • 30 Jul 2010 Actual initiation date added to 1 Mar 2010 as reported by ClinicalTrials.gov.
    • 30 Jul 2010 Actual end date added to 1 Mar 2010 as reported by ClinicalTrials.gov.
    • 30 Jul 2010 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.`
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top